Neuroblastoma imaging using a combined CT scanner-scintillation camera and 131I-MIBG

Area of Science:

• Nuclear Medicine
• Radiopharmaceutical Therapy
• Medical Imaging

Background:

• High-dose radioactive iodine (131I-metaiodobenzylguanidine) is a promising neuroblastoma treatment.
• Current methods for measuring 131I-MIBG uptake in vivo lack accuracy for monitoring patient radiation doses.

Purpose of the Study:

• To evaluate methodologies for improving the localization and uptake measurements of 131I-MIBG.
• To leverage correlated patient data from a combined CT-scintillation camera imaging system.

Main Methods:

• SPECT images were reconstructed using filtered backprojection and MLEM.
• Volumes of interest (VOIs) were defined on CT scans and correlated to SPECT images.
• Lesion activities were estimated using CT-aided methods, mean VOI values from MLEM images, and planar radionuclide images.

Main Results:

• CT-aided quantification methods yielded consistent results for both planar and tomographic radionuclide data.
• Estimates from MLEM images alone were lower than CT-aided methods due to limited SPECT resolution.
• Standard conjugate view methods showed significant discrepancies (up to fivefold) compared to CT-aided approaches.

Conclusions:

• Coregistered CT images enhance in vivo localization of 131I-MIBG uptake in tumors.
• Anatomic information from CT improves the accuracy of uptake measurements.
• This combined imaging approach offers a more precise method for monitoring radiopharmaceutical therapy.